Literature DB >> 22798032

Clinical implications of enteroadherent Escherichia coli.

Margarita M P Arenas-Hernández1, Ygnacio Martínez-Laguna, Alfredo G Torres.   

Abstract

Pathogenic Escherichia coli that colonize the small intestine primarily cause gastrointestinal illness in infants and travelers. The main categories of pathogenic E. coli that colonize the epithelial lining of the small intestine are enterotoxigenic E. coli, enteropathogenic E. coli, and enteroaggregative E. coli. These organisms accomplish their pathogenic process by a complex, coordinated multistage strategy, including nonintimate adherence mediated by various adhesins. These so called "enteroadherent E. coli" categories subsequently produce toxins or effector proteins that are either secreted to the milieu or injected to the host cell. Finally, destruction of the intestinal microvilli results from the intimate adherence or the toxic effect exerted over the epithelia, resulting in water secretion and diarrhea. In this review, we summarize the current state of knowledge regarding these enteroadherent E. coli strains and the present clinical understanding of how these organisms colonize the human intestine and cause disease.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22798032      PMCID: PMC3448025          DOI: 10.1007/s11894-012-0277-1

Source DB:  PubMed          Journal:  Curr Gastroenterol Rep        ISSN: 1522-8037


  69 in total

1.  Future directions for research on enterotoxigenic Escherichia coli vaccines for developing countries.

Authors: 
Journal:  Wkly Epidemiol Rec       Date:  2006-03-17

Review 2.  Enteropathogenic and enterohaemorrhagic Escherichia coli: even more subversive elements.

Authors:  Alexander R C Wong; Jaclyn S Pearson; Michael D Bright; Diana Munera; Keith S Robinson; Sau Fung Lee; Gad Frankel; Elizabeth L Hartland
Journal:  Mol Microbiol       Date:  2011-05-05       Impact factor: 3.501

Review 3.  Enteropathogenic escherichia coli infection in children.

Authors:  Theresa J Ochoa; Carmen A Contreras
Journal:  Curr Opin Infect Dis       Date:  2011-10       Impact factor: 4.915

4.  Characterization of enteroaggregative Escherichia coli (EAEC) clinical isolates and their antibiotic resistance pattern.

Authors:  Mohammad Mehdi Aslani; Mohammad Yousef Alikhani; Ali Zavari; Rasol Yousefi; Ali Reza Zamani
Journal:  Int J Infect Dis       Date:  2010-12-03       Impact factor: 3.623

Review 5.  Enterotoxigenic Escherichia coli in developing countries: epidemiology, microbiology, clinical features, treatment, and prevention.

Authors:  Firdausi Qadri; Ann-Mari Svennerholm; A S G Faruque; R Bradley Sack
Journal:  Clin Microbiol Rev       Date:  2005-07       Impact factor: 26.132

6.  Escherichia coli isolated from a Crohn's disease patient adheres, invades, and induces inflammatory responses in polarized intestinal epithelial cells.

Authors:  Tonyia Eaves-Pyles; Christopher A Allen; Joanna Taormina; Alexander Swidsinski; Christopher B Tutt; G Eric Jezek; Martha Islas-Islas; Alfredo G Torres
Journal:  Int J Med Microbiol       Date:  2007-09-27       Impact factor: 3.473

Review 7.  Pathogenic Escherichia coli.

Authors:  James B Kaper; James P Nataro; Harry L Mobley
Journal:  Nat Rev Microbiol       Date:  2004-02       Impact factor: 60.633

8.  Randomised, double-blind, safety and efficacy of a killed oral vaccine for enterotoxigenic E. Coli diarrhoea of travellers to Guatemala and Mexico.

Authors:  David A Sack; Janet Shimko; Olga Torres; August L Bourgeois; Domingo Sanchez Francia; Björn Gustafsson; Anders Kärnell; Iréne Nyquist; Ann-Mari Svennerholm
Journal:  Vaccine       Date:  2007-04-04       Impact factor: 3.641

9.  Probiotics and gastrointestinal infections.

Authors:  Robert A Britton; James Versalovic
Journal:  Interdiscip Perspect Infect Dis       Date:  2009-02-04

10.  Disease burden due to enterotoxigenic Escherichia coli in the first 2 years of life in an urban community in Bangladesh.

Authors:  Firdausi Qadri; Amit Saha; Tanvir Ahmed; Abdullah Al Tarique; Yasmin Ara Begum; Ann-Mari Svennerholm
Journal:  Infect Immun       Date:  2007-06-04       Impact factor: 3.441

View more
  11 in total

Review 1.  Enteropathogenic Escherichia coli: foe or innocent bystander?

Authors:  J Hu; A G Torres
Journal:  Clin Microbiol Infect       Date:  2015-01-28       Impact factor: 8.067

Review 2.  Epidemiology and clinical manifestations of enteroaggregative Escherichia coli.

Authors:  Betina Hebbelstrup Jensen; Katharina E P Olsen; Carsten Struve; Karen Angeliki Krogfelt; Andreas Munk Petersen
Journal:  Clin Microbiol Rev       Date:  2014-07       Impact factor: 26.132

3.  A Novel Phage Cocktail Therapy of the Urinary Tract Infection in a Mouse Model.

Authors:  B Mijbel Ali; S A Gatea Kaabi; M A Al-Bayati; H K Musafer
Journal:  Arch Razi Inst       Date:  2021-11-30

4.  Influence of environmental factors in the adherence of an atypical enteropathogenic Escherichia coli strain to epithelial cells.

Authors:  Fabiano T Romão; Rodrigo T Hernandes; Denise Yamamoto; Lika Osugui; Ana Flavia Popi; Tânia A T Gomes
Journal:  BMC Microbiol       Date:  2014-12-20       Impact factor: 3.605

5.  Identification and antimicrobial resistance prevalence of pathogenic Escherichia coli strains from treated wastewater effluents in Eastern Cape, South Africa.

Authors:  Martins A Adefisoye; Anthony I Okoh
Journal:  Microbiologyopen       Date:  2016-01-13       Impact factor: 3.139

6.  Population structure of Escherichia coli O26 : H11 with recent and repeated stx2 acquisition in multiple lineages.

Authors:  Yoshitoshi Ogura; Yasuhiro Gotoh; Takehiko Itoh; Mitsuhiko P Sato; Kazuko Seto; Shyuji Yoshino; Junko Isobe; Yoshiki Etoh; Mariko Kurogi; Keiko Kimata; Eriko Maeda; Denis Piérard; Masahiro Kusumoto; Masato Akiba; Kiyoshi Tominaga; Yumi Kirino; Yuki Kato; Katsuhiko Shirahige; Tadasuke Ooka; Nozomi Ishijima; Ken-Ichi Lee; Sunao Iyoda; Jacques Georges Mainil; Tetsuya Hayashi
Journal:  Microb Genom       Date:  2017-11

7.  Adherence and virulence genes of Escherichia coli from children diarrhoea in the Brazilian Amazon.

Authors:  Najla Benevides-Matos; Fabio A Pieri; Marilene Penatti; Patrícia P Orlandi
Journal:  Braz J Microbiol       Date:  2015-03-01       Impact factor: 2.476

8.  Escherichia coli B2 strains prevalent in inflammatory bowel disease patients have distinct metabolic capabilities that enable colonization of intestinal mucosa.

Authors:  Xin Fang; Jonathan M Monk; Nathan Mih; Bin Du; Anand V Sastry; Erol Kavvas; Yara Seif; Larry Smarr; Bernhard O Palsson
Journal:  BMC Syst Biol       Date:  2018-06-11

Review 9.  Environment Controls LEE Regulation in Enteropathogenic Escherichia coli.

Authors:  Amy Platenkamp; Jay L Mellies
Journal:  Front Microbiol       Date:  2018-07-27       Impact factor: 5.640

10.  Virulence factors and antibiograms of Escherichia coli isolated from diarrheic calves of Egyptian cattle and water buffaloes.

Authors:  Nader M Sobhy; Sarah G A Yousef; Hamada A Aboubakr; Muhammad Nisar; Kakambi V Nagaraja; Sunil K Mor; Robert J Valeris-Chacin; Sagar M Goyal
Journal:  PLoS One       Date:  2020-05-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.